MARITESS ESGUERRA, Senior PV Process Director, Genentech

With 25 years experience in the pharmaceutical, biotechnology and academia, Maritess Esguerra has extensive experience in drug safety covering numerous product types (innovators, generics, biosimilar, medical device, product-device combination, and advanced therapeutic medicinal products) in various therapeutic areas, spanning from investigational stage to post-market settings. She is currently a Senior Pharmacovigilance Process Director at Genentech, a member of the Roche group, where she has served as business lead and global process owner of safety processes, systems and tools. She is an active Core Member of the TransCelerate's Interpretation of PV Guidances and Regulations (IGR PV) Workstream and also served as its Regulatory Council Liaison.

Previously, Maritess had a progressive career and held various global and regional safety positions at Alliance Pharmaceutical, Chugai Pharma USA, Amgen, and Puma Biotechnology. Prior to joining the industry, Maritess worked at the University of California San Diego Health Bone Marrow Transplant Unit, coordinating and monitoring clinical trials, and had also conducted epidemiological and pre-clinical research.